Copper(I)‐Thiosemicarbazone Complexes with Dual Anticancer and Antiparasitic Activity
ChemMedChem · 2023
DOI: 10.1002/cmdc.202300074 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2023. Verfasst von João Franco Machado und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Química Estrutural, Institute of Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016, Lisboa, Portuga…. Hauptthemen laut MEDLINE: Thiosemicarbazones, Ovarian Neoplasms, Anti-Infective Agents, Chagas Disease. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Four new Cu(I) complexes of the general formula [Cu(PP)(LL)][BF 4 ], in which PP is a phosphane ligand (triphenylphosphane or 1,2‐bis(diphenylphosphano)ethane (dppe)) and LL is a bioactive thiosemicarbazone ligand (4‐(methyl)‐1‐(5‐nitrofurfurylidene)thiosemicarbazone) or 4‐(ethyl)‐1‐(5‐nitrofurfurylidene)thiosemicarbazone) were synthesized and fully characterized by classical analytical and spectroscopic methods. The anti‐trypanosome and anticancer activities were investigated in vitro on Trypanosoma cruzi and in two human cancer cell lines (ovarian OVCAR3 and prostate PC3). To test the selectivity toward parasites and cancer cells, the cytotoxicity on normal monkey kidney VERO and human dermal fibroblasts HDF cells was also evaluated. The new heteroleptic complexes were more cytotoxic on T. cruzi and chemoresistant prostate PC3 cells than the benchmark drugs nifurtimox and cisplatin. The compounds also showed a high level of cellular internalization by the OVCAR3 cells and, in particular, those containing the dppe phosphane showed activation of the cell death mechanism via apoptosis. On the other hand, the production of reactive oxygen species induced by these complexes was not evident.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Química Estrutural, Institute of Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016, Lisboa, Portugal.
- Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016, Lisboa, Portugal.
- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional, 2695-066, Bobadela LRS, Portugal.
- Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional, 2695-066, Bobadela LRS, Portugal.
- iBB - Instituto de Bioengenharia e Biociências, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais 1, 1049-001, Lisboa, Portugal.
- Área Química Inorgánica, Facultad de Química, Universidad de la República, Gral. Flores 2124, 11800, Montevideo, Uruguay.
ORCID-Profile: Tânia S Morais
Zitieren
APA
Machado, J. F., Marques, F., Pinheiro, T., Villa de Brito, M. J., Scalese, G., Pérez-Díaz, L., Otero, L., António, J. P. M., Gambino, D., & Morais, T. S. (2023). Copper(I)‐Thiosemicarbazone Complexes with Dual Anticancer and Antiparasitic Activity. ChemMedChem. https://doi.org/10.1002/cmdc.202300074
Vancouver
Machado JF, Marques F, Pinheiro T, Villa de Brito MJ, Scalese G, Pérez-Díaz L, et al. Copper(I)‐Thiosemicarbazone Complexes with Dual Anticancer and Antiparasitic Activity. ChemMedChem. 2023. doi:10.1002/cmdc.202300074
BibTeX
@article{Machado2023,
author = {Machado, João Franco and Marques, Fernanda and Pinheiro, Teresa and Villa de Brito, Maria J and Scalese, Gonzalo and Pérez-Díaz, Leticia and Otero, Lucía and António, João P M and Gambino, Dinorah and Morais, Tânia S},
title = {Copper(I)‐Thiosemicarbazone Complexes with Dual Anticancer and Antiparasitic Activity},
journal = {ChemMedChem},
year = {2023},
doi = {10.1002/cmdc.202300074}
}
EUVIMED